GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » Buildings And Improvements

Genus (FRA:GBE) Buildings And Improvements : €72.0 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Genus Buildings And Improvements?

Genus's quarterly buildings and improvements declined from Dec. 2022 (€37.1 Mil) to Jun. 2023 (€36.9 Mil) but then increased from Jun. 2023 (€36.9 Mil) to Dec. 2023 (€72.0 Mil).

Genus's annual buildings and improvements increased from Jun. 2021 (€24.1 Mil) to Jun. 2022 (€36.7 Mil) and increased from Jun. 2022 (€36.7 Mil) to Jun. 2023 (€36.9 Mil).

Genus Buildings And Improvements Historical Data

The historical data trend for Genus's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genus Buildings And Improvements Chart

Genus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 24.10 36.70 36.94

Genus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 36.70 37.14 36.94 71.97

Genus Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

Genus (FRA:GBE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (FRA:GBE) » Definitions » Buildings And Improvements
Comparable Companies
LSE:ONT LSE:PRTC LSE:BVXP LSE:OXB LSE:HVO LSE:AVCT LSE:4BB LSE:FUM LSE:FARN LSE:SCLP OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
GENSF:USA GNSl:UK GNS:UK
Address
Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ
Website
https://www.genusplc.com
Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.

Genus (FRA:GBE) Headlines

No Headlines